Diligence memo · auto-generated · as of July 2, 2026

Visiogen Inc

Visiogen Inc looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Visiogen Inc operates in Other Health Care, based in IRVINE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Visiogen Inc has raised $20M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $20M on 2009-04-20.

Most recent recorded round closed around 2009-04-20.

Valuation (modeled)modeled

Provath models Visiogen Inc at approximately $443M (range $47M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.94× the median modeled value of Series B Other Health Care companies in 2007–2009 (19 peers) — value vs value, same stage and era. Within the normal band (94% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 17.2 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 84% of Other Health Care peers (5377 compared).

Modeled value ranks above 93% of those peers.

Closest niche peers: Medical Imaging Holdings, Inc., ev3 Inc., Avalign Technologies Holdings, Inc., GEMCare Mercy Memorial Health System LLC, Metagenics, Inc..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.